Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.63
+0.08 (1.13%)
Oct 12, 2026, 12:31 PM EDT - Market open
Ocular Therapeutix Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $31 | Buy | Maintains | $31 | +306.56% | Oct 12, 2026 |
| UBS No rating | UBS | Buy Initiates $14 | Buy | Initiates | $14 | +83.61% | Oct 11, 2026 |
| Needham | Needham | Buy Maintains $18 | Buy | Maintains | $18 | +136.07% | Sep 28, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +227.87% | Sep 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $27 | Buy | Maintains | $27 | +254.10% | Sep 16, 2026 |
| Clear Street | Clear Street | Buy Reiterates $28 | Buy | Reiterates | $28 | +267.21% | Aug 18, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $20 | Buy | Maintains | $20 | +162.30% | Aug 4, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.